UY26404A1 - METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE - Google Patents
METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASEInfo
- Publication number
- UY26404A1 UY26404A1 UY26404A UY26404A UY26404A1 UY 26404 A1 UY26404 A1 UY 26404A1 UY 26404 A UY26404 A UY 26404A UY 26404 A UY26404 A UY 26404A UY 26404 A1 UY26404 A1 UY 26404A1
- Authority
- UY
- Uruguay
- Prior art keywords
- phosphodiesterase
- methods
- polynucleotides
- polypeptides
- cyclic nucleotide
- Prior art date
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Métodos para usar una fosfodiesterasa humana de nucleótidos cíclicos de la superfamilia de las fosfodiesterasas de mamíferos. Métodos para usar los polinucleótidos que codifican la fosfodiesterasa. Métodos para usar los polipéptidos y polinucleótidos de la fosfodiesterasa como blanco para diagnosis y tratamiento de afecciones mediadas o relacionadas con la fosfodiesterasa. Métodos para el análisis de drogas que usan los polipéptidos y los polinucleótidos de la fosfodiesterasa para identificar agonistas y antagonistas para diagnosis y tratamientos. Agonistas y antagonistas basados en los polipéptidos y polinucleótidos de la fosfodiesterasa. Agonistas y antagonistas identificados por medio de los métodos de análisis de drogas con los polipéptidos y los polinuclótidos de la fosfodiesterasa como blanco.Methods for using a human cyclic nucleotide phosphodiesterase from the mammalian phosphodiesterase superfamily. Methods for using polynucleotides encoding phosphodiesterase. Methods for using phosphodiesterase polypeptides and polynucleotides as a target for diagnosis and treatment of phosphodiesterase-related or mediated conditions. Drug testing methods that use phosphodiesterase polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. Agonists and antagonists based on phosphodiesterase polypeptides and polynucleotides. Agonists and antagonists identified by drug analysis methods with phosphodiesterase polypeptides and polynucleotides targeted.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY26404A UY26404A1 (en) | 2000-10-18 | 2000-10-18 | METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY26404A UY26404A1 (en) | 2000-10-18 | 2000-10-18 | METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26404A1 true UY26404A1 (en) | 2001-06-29 |
Family
ID=38812267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26404A UY26404A1 (en) | 2000-10-18 | 2000-10-18 | METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE |
Country Status (1)
Country | Link |
---|---|
UY (1) | UY26404A1 (en) |
-
2000
- 2000-10-18 UY UY26404A patent/UY26404A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI200700158A (en) | GLP-1 AGONISTS, COMPOSITIONS, METHODS AND USES | |
Mathy et al. | Synaptically induced long-term modulation of electrical coupling in the inferior olive | |
CR11042A (en) | ANTIBODIES OX40 ANTAGONISTS AND ITS USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES | |
AR051524A1 (en) | PATIENT SELECTION FOR A THERAPY WITH A HER INHIBITOR | |
CO6362020A2 (en) | MUTANTS FGF21 AND USE OF THE SAME | |
ECSP077985A (en) | PROTEIN CINASE INHIBITORS DERIVED FROM PIRROL (2,3-B) PIRIDINE | |
ES2572372T3 (en) | Diagnostic method of neurodegenerative diseases based on the measurement of levels or activity of SIRT1 | |
AR062709A1 (en) | ANTAGONISTS OF THE WNT GEN AND ITS USE IN THE DIAGNOSIS AND TREATMENT OF DISORDERS MEDIATED BY THE WNT | |
AR030236A1 (en) | MOLECULES SIMILAR TO IL-17 AND USES OF THE SAME | |
BRPI0413563A (en) | compounds and compositions as inhibitors of tyrosine kinase receptor activity | |
UY30779A1 (en) | USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE | |
AR084373A1 (en) | COMPOSITIONS AND METHODS FOR THE ELIMINATION OF BIOPELLICLES | |
DE602008006748D1 (en) | PORTABLE MEDICAL DEVICE WITH SAMPLE DETERGENT, DETERGENT AND INJECTION AGENT | |
DOP2010000076A (en) | IMPROVED DETECTION OF MAGE-A EXPRESSION | |
CR11562A (en) | BIS-PIRIDILPIRIDONAS AS ANTAGONISTS OF THE RECEIVER 1 OF THE CONCENTRATING HORMONE OF MELANINA | |
BR112015011723A2 (en) | screening for tuberculosis using cpd data | |
ATE555814T1 (en) | RADIOACTIVE AGENTS FOR IN VIVO PET IMAGING OF CCR5 | |
PE20211304A1 (en) | THERAPEUTIC AND DIAGNOSTIC METHODS FOR INFLAMMATORY DISEASES MEDIATED BY MASTOCYTES | |
UY32556A (en) | DERIVATIVES OF QUINAZOLINADIONA, ITS PREPARATION AND ITS VARIOUS THERAPEUTIC APPLICATIONS | |
DOP2000000081A (en) | METHODS TO USE 22045, A HUMAN PHOSPHODYSTERASE OF CYCLIC NUCLOSIDS | |
DK1949903T3 (en) | Selective A2A receptor antagonists for the treatment of atrial fibrillation | |
PE20180577A1 (en) | USE OF THE IL-3, IL-33 AND IL-12p40 MOLECULAR MARKERS TO CHARACTERIZE THE SEVERITY OF RESPIRATORY INFECTIONS BY RESPIRATORY SYNCITIAL VIRUS AND HUMAN METAPNEUMOVIRUS | |
AR029581A1 (en) | METHODS FOR THE IDENTIFICATION OF COMBINATIONS OF ENTITIES AS THERAPEUTIC AGENTS | |
UY26404A1 (en) | METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE | |
BR112021009441A2 (en) | Multiplexing highly evolving viral variants with Sherlock |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20121121 |